Reducing the glycan heterogeneity of recombinant proteins may improve the efficacy of biopharmaceuticals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Lepenies, B., Yin, J. & Seeberger, P.H. Curr. Opin. Chem. Biol. 14, 404–411 (2010).
Meuris, L. et al. Nat. Biotechnol. 32, 485–487 (2014).
Rich, J.R. & Withers, S.G. Nat. Chem. Biol. 5, 206–215 (2009).
Schwarz, F. et al. Nat. Chem. Biol. 6, 264–266 (2010).
Hamilton, S.R. et al. Science 313, 1441–1443 (2006).
Castilho, A. et al. Glycobiology 21, 813–823 (2011).
Aumiller, J.J., Mabashi-Asazuma, H., Hillar, A., Shi, X. & Jarvis, D.L. Glycobiology 22, 417–428 (2012).
Wang, Z. et al. Science 341, 379–383 (2013).
Wang, P. et al. Science 342, 1357–1360 (2013).
Seeberger, P.H. & Werz, D.B. Nature 446, 1046–1051 (2007).
Reeves, P.J., Callewaert, N., Contreras, R. & Khorana, H.G. Proc. Natl. Acad. Sci. USA 99, 13419–13424 (2002).
Lepenies, B., Lee, J. & Sonkaria, S. Adv. Drug Deliv. Rev. 65, 1271–1281 (2013).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Lepenies, B., Seeberger, P. Simply better glycoproteins. Nat Biotechnol 32, 443–445 (2014). https://doi.org/10.1038/nbt.2893
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2893